Innoviva (INVA) Misses Q1 EPS by 107c

Innoviva (NASDAQ: INVA) reported Q1 EPS of ($0.74), $1.07 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $88.63 million versus the consensus estimate of $81.63 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Senate votes to halt Iran war unless Trump gets approval from Congress
• Backblaze (BLZE) call put ratio 12.9 calls to 1 put with a focus on July 12.50 calls as share price up 40%
• SCWorx gets Nasdaq panel approval to maintain listing with conditions